After establishing a subcutaneous xenotransplanted tumor model of CAFs plus HCC cells in mice, we set out to validate the effects of LINC00152 knockdown and CXCL11 overexpression on tumor growth in vivo. The gene discussed is CXCL11; the disease is neoplasm.